EU is asked to approve extra dose from Pfizer vaccine vials



© Reuters. Exterior of EMA, European Medicines Agency is seen in Amsterdam

By Jan Lopatka and Emilio Parodi

PRAGUE/ROME (Reuters) – The European Union was asked on Tuesday to allow an extra dose of the COVID-19 vaccine developed by Pfizer (NYSE:) and BioNTech to be taken from each vial, a practice allowed elsewhere that would make scarce supplies go further.

Experts say it is possible to obtain six doses from each vial, more than the five approved by the European Medicines Agency (EMA).

Czech Prime Minister Andrej Babis said he had raised the matter with European Commission President Ursula von der Leyen with a view to seeking EMA clearance for the extra shot as soon as possible.

The vaccine, made by Pfizer of the United States and the German biotech startup BioNTech, is the only one to win EU approval so far, and is already being administered.

But supplies are tight and rising coronavirus infections are stretching hospitals to the limit.

BioNTech said each vial was guaranteed to yield five doses, but that it was possible, with the right needle and syringe, to extract a sixth.

“We are in discussions with regulatory authorities whether and how the sixth dose, as well as the required needles or syringes for such a low-dead-volume system, could be made available,” a BioNTech spokesperson said.

Italian regulators have already approved the drawing of six doses, overriding EMA guidance for the EU as a whole.

Similar approvals have been issued by regulators in the United States, Britain, Switzerland and Israel – which all made an earlier start to their vaccination campaigns.

READ  Businessman Shetty seeks India probe of NMC, Finablr ex-CEOs over $6 billion scandal

Soren Brostrom, head of the Danish Health Authority, said it was even possible to draw a seventh dose from some Pfizer vials, and that it might be feasible to vaccinate more than the 250,000 people envisaged in the first two months of Denmark’s campaign.

The EU has signed deals to buy a total of 2 billion vaccine doses, which will be distributed to member states in proportion to their populations. The EMA did not respond to a request for comment.

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.





READ SOURCE

LEAVE A REPLY

Please enter your comment!
Please enter your name here